Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2017 | 2 |
2020 | 2 |
2021 | 2 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
A DNA Methylation-Based Gene Signature Can Predict Triple-Negative Breast Cancer Diagnosis.
Biomedicines. 2021 Oct 4;9(10):1394. doi: 10.3390/biomedicines9101394.
Biomedicines. 2021.
PMID: 34680511
Free PMC article.
CDH22 hypermethylation is an independent prognostic biomarker in breast cancer.
Martín-Sánchez E, Mendaza S, Ulazia-Garmendia A, Monreal-Santesteban I, Córdoba A, Vicente-García F, Blanco-Luquin I, De La Cruz S, Aramendia A, Guerrero-Setas D.
Martín-Sánchez E, et al. Among authors: mendaza s.
Clin Epigenetics. 2017 Jan 24;9:7. doi: 10.1186/s13148-016-0309-z. eCollection 2017.
Clin Epigenetics. 2017.
PMID: 28149335
Free PMC article.
Item in Clipboard
ADAM12 is A Potential Therapeutic Target Regulated by Hypomethylation in Triple-Negative Breast Cancer.
Mendaza S, Ulazia-Garmendia A, Monreal-Santesteban I, Córdoba A, Azúa YR, Aguiar B, Beloqui R, Armendáriz P, Arriola M, Martín-Sánchez E, Guerrero-Setas D.
Mendaza S, et al.
Int J Mol Sci. 2020 Jan 30;21(3):903. doi: 10.3390/ijms21030903.
Int J Mol Sci. 2020.
PMID: 32019179
Free PMC article.
Item in Clipboard
CHL1 hypermethylation as a potential biomarker of poor prognosis in breast cancer.
Martín-Sánchez E, Mendaza S, Ulazia-Garmendia A, Monreal-Santesteban I, Blanco-Luquin I, Córdoba A, Vicente-García F, Pérez-Janices N, Escors D, Megías D, López-Serra P, Esteller M, Illarramendi JJ, Guerrero-Setas D.
Martín-Sánchez E, et al. Among authors: mendaza s.
Oncotarget. 2017 Feb 28;8(9):15789-15801. doi: 10.18632/oncotarget.15004.
Oncotarget. 2017.
PMID: 28178655
Free PMC article.
Item in Clipboard
Absence of Nuclear p16 Is a Diagnostic and Independent Prognostic Biomarker in Squamous Cell Carcinoma of the Cervix.
Mendaza S, Fernández-Irigoyen J, Santamaría E, Zudaire T, Guarch R, Guerrero-Setas D, Vidal A, Santos-Salas J, Matias-Guiu X, Ausín K, Díaz de Cerio MJ, Martín-Sánchez E.
Mendaza S, et al.
Int J Mol Sci. 2020 Mar 19;21(6):2125. doi: 10.3390/ijms21062125.
Int J Mol Sci. 2020.
PMID: 32204550
Free PMC article.
Item in Clipboard
Understanding the Molecular Mechanism of miR-877-3p Could Provide Potential Biomarkers and Therapeutic Targets in Squamous Cell Carcinoma of the Cervix.
Mendaza S, Fernández-Irigoyen J, Santamaría E, Arozarena I, Guerrero-Setas D, Zudaire T, Guarch R, Vidal A, Salas JS, Matias-Guiu X, Ausín K, Gil C, Hernández-Alcoceba R, Martín-Sánchez E.
Mendaza S, et al.
Cancers (Basel). 2021 Apr 6;13(7):1739. doi: 10.3390/cancers13071739.
Cancers (Basel). 2021.
PMID: 33917510
Free PMC article.
Item in Clipboard
Cite
Cite